Case Study

How Catalent Biologics Speeds Up Cell Line Development

Cells iStock-999018482

Catalent Biologics, part of Catalent Inc., takes biologics from cell line development through to finished product supply using their proprietary GPEx® Cell Line Development technology, which creates stable, high-yielding mammalian cell lines for even the most difficult to express proteins. See how they were able to speed up their process and get the best clones by investing in the Beacon® optofluidic system from Berkeley Lights.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: